Regenicin Inc

(RGIN)

By |

Profile

Regenicin Inc is a biotechnology company based in the US. It focuses on developing and commercializing a lifesaving technology by the introduction of tissue-engineered skin substitutes to restore the qualities of healthy human skin for use in the treatment of burns, chronic wounds and a range of plastic surgery procedures. The company's key product includes NovaDerm, which is a cultured skin substitute product for medical use on burns requiring grafting. and cell therapy and biotechnology products.

Contact Information

Website: www.regenicin.com
Main Phone: +1 973 557-8914
Address: 10 High Court
State: NJ
City / Town: Little Falls
Country: USA
Postal Code: 7424

Issuer Information

Exchange: OTO
CEO: Randall E. McCoy
Employees: 3
NAICS: In-Vitro Diagnostic Substance Manufacturing(325413)
$ 0.020515 $ -0.00012 (-0.58%)
Last Price 0.020515 Change $ -0.00012 Change % -0.58 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open 0.020515 High 0.020515 Low 0.020515 Prev Close 0.020635
Last Trade Volume 24,040 52 Wk Hi 0.14 52 Wk Low 0.002
Market Cap 3.1 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 153,483,050.00 EPS (TTM) -0.01 PE Ratio N/A Exchange OTCPK